Burning Rock Biotech Ltd - Company Profile
Powered by 
All the sales intelligence you need on Burning Rock Biotech Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Burning Rock Biotech Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Burning Rock Biotech Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Burning Rock Biotech Ltd (BRB) is a biotechnology company that focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. The company products include solid tumor testing products, minimal residual disease testing kits, hematologic malignancies testing kits, multi-omics detection kits and early cancer detection products. BRB services include pharma biomarker and CDx services, IVD channel partner development, sequencing services and early cancer detection services. It offers its products under the brands OncoScreen, CanCatch and OverC. The company operates in China and the US. BRB is headquartered in Guangzhou, Guangdong, China.
Burning Rock Biotech Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Solid Tumor Testing | Pharma Biomarker and CDx Services | OncoScreen |
| CDx Tissue Kit | IVD Channel Partner Development | OncoCompass |
| Cancer Mutation Profiling Tissue Kit | Sequencing Services | CanCatch |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
Competitor Comparison
| Key Parameters | Burning Rock Biotech Ltd | BGI Genomics Co Ltd | Novogene Co Ltd | AmoyDx (Canada) Ltd | Creative Biosciences (Guangzhou) Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | Canada | China |
| City | Guangzhou | Shenzhen | Beijing | Vancouver | Guangzhou |
| State/Province | Guangdong | Guangdong | Beijing | British Columbia | Guangdong |
| No. of Employees | 667 | 3,580 | 2,225 | - | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Yusheng Han | Chairman; Chief Executive Officer | Executive Board | 2013 | 46 |
| Zhihong Joe Zhang | Chief Technology Officer; Director | Executive Board | 2023 | 49 |
| Xinru Mao | Head - Pharma Biomarker and CDx Service; Head - International IVD Business | Senior Management | 2015 | - |
| Xiaozhi Hu | Senior director - Finance | Senior Management | 2012 | 41 |
| Gang Lu | Director | Non Executive Board | 2014 | 53 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer